Concepedia

Author

Lushan Xiao

Nanfang HospitalORCID

Also Known As

Hong Zhu, L Xiao, L. Xiao, Lu-Shan Xiao, Lu-shan Xiao, Lushan Xiao, Lu‐Shan Xiao, Xiao Lushan, Xiao, Lushan

63

Publications

751

Citations

17

H-Index

38

Concepts

All Affiliations

Nanfang HospitalSouthern Medical UniversityUniversity of South ChinaFirst Affiliated Hospital of University of South ChinaAffiliated Hospital of Guizhou Medical University
LX

About

Lushan Xiao is an author at Nanfang Hospital specializing in medicine, tumor biology, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

111

2

Engineering

1

1

52

3

Health Sciences

1

1

13

4

Social Sciences

1

1

52

5

Biochemistry

1

1

13

Lushan Xiao

×

24

Publications

615

Citations

16

H-Index

YearCitations

UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway

Wei Hu, Lushan Xiao, Chuanhui Cao,

Oncotarget

2016

62

AMDET: Attention Based Multiple Dimensions EEG Transformer for Emotion Recognition

Yongling Xu, Yang Du, Ling Li,

IEEE Transactions on Affective Computing

2023

52

Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019

Lushan Xiao, Wenfeng Zhang, Mengchun Gong,

EBioMedicine

2020

45

Positive association of nap duration with risk of non-alcoholic fatty liver disease in an occupational population in Guangdong Province, China: a cross-sectional study

Chang Hong, Chengkai Wu, Pengcheng Ma,

BMC Gastroenterology

2022

41

Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies

Lin Zeng, Yan Li, Hong Chang,

Osteoporosis International

2024

39

Radiomics-based nomogram using CT imaging for noninvasive preoperative prediction of early recurrence in patients with hepatocellular carcinoma

Hongbo Zhu, Zeyu Zheng, Heng Zhao,

Diagnostic and Interventional Radiology

2020

36

A high reticulocyte count is a risk factor for the onset of metabolic dysfunction-associated steatotic liver disease: Cross-sectional and prospective studies of data of 310,091 individuals from the UK Biobank

Peng‐Cheng Ma, Qimei Li, Ruining Li,

Frontiers in Pharmacology

2024

34

Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors

Lushan Xiao, Chengyi Hu, Hao Cui,

Cancer Medicine

2022

31

Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort study

Lushan Xiao, Rui-ning Li, Hao Cui,

BMC Cancer

2022

27

Chromobox homolog 8 (CBX8) Interacts with Y-Box binding protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells

Lushan Xiao, Zixiao Zhou, Wenwen Li,

Aging

2019

23

Page 1